Find Academic Supervisors

Hai-Quan Mao is a Professor of Materials Science and Engineering at Johns Hopkins University, with a joint appointment in the Biomedical Engineering Department (School of Medicine). He directs the Institute for NanoBioTechnology (INBT) and leads the Translational Tissue Engineering Center. His research focuses on biomaterials, regenerative engineering, and immunoengineering, particularly developing nanomaterials for therapeutic delivery and tissue regeneration. Mao holds 35 U.S. patents, co-founded two biotech companies, and received prestigious awards including National Academy of Inventors Fellow and NSF CAREER Award. Education: BS in Chemistry (1988) and PhD in Polymer Chemistry (1993) from Wuhan University. Postdoctoral training at Johns Hopkins (1995–1998), followed by roles at Johns Hopkins Singapore (1999–2003) before joining the Whiting School faculty. Research emphasizes nanofiber scaffolds for liver/nerve regeneration, DNA/lipid nanoparticle engineering for gene therapy, and artificial lymph node matrices for immunotherapy. His lab translates biomaterials innovations into clinical applications, with NIH-funded projects addressing cancer, malaria, and tissue damage. Awards include over 60 provisional patents, multiple Johns Hopkins translational awards, and Thalheimer Awards for research. He serves as associate editor of Biomaterials and editorial board member of major journals. Lab activities include scalable nanoparticle manufacturing, machine learning for material design, and collaborations with industry/clinical partners. Recent work includes lipid nanoparticle optimization for mRNA vaccines and exosome-based therapies for Crohn’s disease.

• Biomaterials
• Regenerative Engineering
• Therapeutic Delivery
• +3 more

Bradley D. Olsen is a full professor in the Department of Chemical Engineering at the Massachusetts Institute of Technology (MIT), where he leads research at the intersection of polymer science, soft matter physics, and bioengineering. His work focuses on designing materials for critical applications in biotechnology, hemostasis, and sustainable polymer development while advancing fundamental understanding of polymer network mechanics and self-assembly. Education: Ph.D. in Chemical Engineering, University of California Berkeley (2007) S.B. in Chemical Engineering, Massachusetts Institute of Technology (2003) Olsen's research spans protein-based materials, block copolymer phase behavior, and mechanochemical hydrogels. He has pioneered methods for quantifying polymer network topology, developing hemostatic nanoparticles, and creating bio-inspired materials for selective biomolecular transport and medical applications. His recent publications emphasize data-driven approaches to polymer characterization and educational outreach in materials science. Scientific Awards: American Physical Society (APS) Fellow (2023) Fulbright Amazonia Scholar (2023) Alexander and I. Michael Kasser Chair in Chemical Engineering (2021) ACS Macro Letters Young Investigator Award (2021) MIT Committed to Caring Honor (2019) AIChE Owens Corning Early Career Award (2019) APS Dillon Medal (2018) Kavli Emerging Leader in Chemistry (2017) ACS Polymer Division Fellow (2016) Camille Dreyfus-Teacher Scholar (2015) Alfred P. Sloan Research Fellow (2014) NSF Career Grant (2013) NIH Postdoctoral Fellowship (2008-2009) Hertz Fellow (2003-2007) Barry M. Goldwater Scholarship (2002) Olsen has received significant grant support including NSF Career (2013) and AFOSR (2012) awards. His teaching activities include innovative international outreach like the 2025 soccer-themed science camp in Brazil. The Olsen Group at MIT explores advanced materials with applications ranging from trauma care to sustainable polymers.

• Polymer Science
• Materials Engineering
• Soft Condensed Matter Physics
• +4 more

Michael McAlpine is a Professor in the Mechanical Engineering department at the University of Minnesota . He also holds affiliations with the Biomedical Engineering and Electrical and Computer Engineering departments. His research focuses on 3D printing functional materials & devices , Nanoscale inks , Biomedical devices , Bioelectronics , and Flexible Microsystems . Research Interests : 3D Printing, Biomedical Engineering, Nanotechnology, Flexible Electronics, Microfluidics Labs : ME 361/363 Contact : mcalpine@umn.edu , (612) 626-3303, ME 117 Recent Research Trends include 3D Printed Biomedical Devices , Flexible Electronics , and Bioprinting Applications . His work spans from Spinal Organoid Formation to Programmable Drug Release Capsules . Scientific Award : Circulation Research 2020 Best Manuscript Award

• 3D Printing
• Nanotechnology
• Biomedical Engineering
• +4 more

Matthew L Becker is the Hugo L Blomquist Distinguished Professor of Chemistry at Duke University, with additional appointments in Mechanical Engineering and Material Science, and Biomedical Engineering. His research focuses on polymer chemistry, bioconjugate chemistry, molecular imaging, additive manufacturing, and degradable materials for bone, soft tissue, neural, and vascular tissue engineering. Education: B.S. from Northwest Missouri State University (1998), M.A. (2000) and Ph.D. (2003) from Washington University in St. Louis Research interests include developing tunable degradable polymers for flexible electronics, tissue engineering (bone, neural, vascular), and additive manufacturing. His group is pioneering 3D printing of bioresorbable medical devices and custom inks for biomaterials. Recent work explores stereochemistry-dependent polymer properties, mechanochromism, and machine learning-driven biomaterials design. Key applications: Drug delivery systems Biodegradable adhesives Tissue regeneration scaffolds Scientific honors include: Fellow, National Academy of Inventors (2022) Fellow, American Chemical Society (2020) Carl S. Marvel Award in Creative Polymer Chemistry (2019) Fellow, American Institute for Medical and Biomedical Engineering (2018) Fellow, Royal Society of Chemistry (2017) Biomacromolecules/Macromolecules Young Investigator Award (2015) He teaches advanced courses in mechanical engineering and polymer chemistry, with a focus on 3D printing and biomaterials. His group has developed novel medical devices including resorbable suture anchors, hernia mesh coatings, and neuroprosthetic scaffolds.

• Polymer chemistry
• Bioconjugate chemistry
• Molecular imaging
• +5 more

Hyun (Michel) Koo is a Professor at the University of Pennsylvania School of Dental Medicine , with affiliations in the Department of Orthodontics , Division of Community Oral Health , and Division of Pediatric Dentistry . As Co-Founder and Co-Director of the Center for Innovation & Precision Dentistry (CiPD) , he leads interdisciplinary efforts merging bioengineering, nanotechnology, and oral health research. Education : DDS and PhD Research Focus : Biofilms, bacterial-fungal interactions, and nanotechnology for oral disease prevention Leadership : Co-Director of CiPD; key roles in training programs like NIDCR-sponsored R90 and T90/R90 Dr. Koo’s research explores biofilm mechanisms in oral infectious diseases, particularly childhood caries, through engineering methods and microrobotics . His team developed micron-scale robots for automated biofilm eradication and FDA-approved nanoparticles for caries prevention. Collaborations with Penn Engineering, including Dr. Daeyeon Lee and Dr. Kacy Cullen, emphasize translational approaches. The 15 most recent publications highlight his work in nanorobotics , interkingdom biofilms , and precision diagnostics . Articles span 2025–2024 and address topics like adaptive micromotors , biofilm matrix degradation , and single-cell microbial interactions . These emphasize his focus on targeted therapies and biofilm microenvironment engineering . Key Awards : Elected Fellow, American Association for the Advancement of Science (AAAS) IADR Distinguished Scientist Award for innovative dental research Dr. Koo trains next-generation researchers through the CiPD NIDCR T90/R90 Postdoctoral Training Program , mentoring fellows like Smruti Nair (ACE2 Chewing Gum development) and Zhi Ren (K99 awardee). His work intersects with Penn Health-Tech, CT3N , and Penn Institute for Biomedical Informatics , fostering transdisciplinary innovation.

• Biofilms
• Oral Infectious Diseases
• Nanotechnology
• +3 more

Dr. Kai Gong is an Assistant Professor of Civil and Environmental Engineering at Rice University, with affiliations at the Rice Advanced Materials Institute and Ken Kennedy Institute. His research focuses on sustainable infrastructure materials, environmental sustainability, and materials science. He holds a Ph.D. in Civil & Environmental Engineering and Materials Science from Princeton University, an MEngSci from Monash University (Australia), and dual B.S. degrees from Monash University and Central South University (China). Research Interests: Development of durable, sustainable infrastructure materials Waste encapsulation and conversion to value-added products Carbon mineralization and utilization Advanced characterization techniques (synchrotron/neutron scattering) Data-driven modeling and atomistic simulations Notable Awards: 2023 Le Chatelier Medal (Cement and Concrete Research) 2024 Giatec Award for Best Paper in Sustainability Walbridge Fund Graduate Award (2019) His work integrates computational methods (e.g., molecular dynamics) with experimental techniques to address decarbonization challenges in infrastructure. The Gong Research Group actively seeks motivated researchers for opportunities in sustainable materials innovation.

• Sustainable Infrastructure Materials
• Environmental Sustainability
• Materials Science
• +4 more

Andrew D. White is an Associate Professor of Chemical Engineering at the Hajim School of Engineering & Applied Sciences, University of Rochester. He holds a PhD from the University of Washington (2013). His research focuses on automating scientific discovery through AI, particularly leveraging large language models (LLMs) and deep learning techniques in chemistry. His lab develops agents that integrate literature analysis, hypothesis generation, and experimental design to advance fields like molecular dynamics and drug discovery. Education: PhD in Chemical Engineering, University of Washington, 2013 BS/MS (not explicitly stated in text, inferred from career timeline) Research Interests: Large language models for scientific automation Deep learning applications in chemistry and materials science Molecular dynamics simulations Scientific agents and autonomous systems Publications: His work includes groundbreaking studies on closed-loop AI systems for chemistry, federated learning in molecular property prediction, and multi-agent systems for drug discovery. Recent highlights include the Robin system and ChemCrow tools. Awards: Recipient of the NSF Career Award (2018), NIH Outstanding Investigator Award (2020), and the Curtis Teaching Award (2019). He also advises biotech companies and serves on the National Academy of Sciences' Chemical Sciences Roundtable. Grants & Funding: Supported by DOE, NSF (multiple grants including CBET-1751471), NIH (R35GM137966), and LLNL projects. Collaborates with institutions like Argonne National Lab and Qubit Pharmaceuticals. Labs & Teams: Leads the White Lab at Rochester and co-founded FutureHouse, a nonprofit advancing AI-driven scientific discovery. Supervises a multidisciplinary team of PhD students and postdocs in computational chemistry, AI, and biophysics.

• Large language models
• Deep learning in chemistry
• Molecular dynamics
• +5 more

Jered Haun is an Associate Professor at the Samueli School of Engineering , University of California, Irvine , with joint appointments in Biomedical Engineering , Chemical and Biomolecular Engineering , and Materials Science and Engineering . Based in 3107 Natural Sciences II , his research focuses on developing nanoengineering and molecular medicine technologies to improve disease diagnosis and treatment. Email: jered.haun@uci.edu Phone: (949) 824-1243 Research Interests include: Nanomaterial Probes for molecular profiling and disease detection Microfabricated Platforms for cell analysis and tissue processing Targeted Delivery Carriers that interact with unique disease molecules Technologies employed in his lab encompass: Fluorescence imaging and MRI enhancements Bioorthogonal chemistry and nanosensor development Micro-NMR for tumor analysis Quantum dot-based detection systems Awards include: NIH National Cancer Institute's Innovative Molecular Analysis Technologies Funding The Haun Laboratory actively recruits graduate and undergraduate students for projects related to nanoengineering, molecular medicine, and microfluidic device development.

• Biomedical Engineering
• Molecular Medicine
• Nanotechnology
• +4 more

Christopher E. Nelson is an Assistant Professor in the Department of Biomedical Engineering at the University of Arkansas, College of Engineering. His lab focuses on developing biologically inspired strategies for controlled drug and gene delivery, particularly in the context of gene therapy and regenerative medicine. He is actively supported by the NIH, DoD, and Arkansas Bioscience Institute. Education: Postdoctoral Fellow – Duke University Ph.D. – Vanderbilt University B.S. – University of Arkansas Research Focus: Dr. Nelson’s lab integrates genome editing technologies with targeted delivery systems to address challenges in treating genetic diseases and promoting tissue regeneration. Major themes include CRISPR/Cas9 delivery , gene regulation in wound healing , and safe-harbor genome integration in skeletal muscle. His work spans viral and non-viral delivery vehicles , including lipid nanoparticles and AAV vectors, with a strong emphasis on preclinical validation in models of Duchenne muscular dystrophy and inflammatory disease. Scientific Awards: Controlled Release Society Postdoctoral Fellowship The Hartwell Foundation Postdoctoral Fellowship NIH Pathway to Independence Award (K99/R00) Funding & Support: The Nelson Lab is currently funded by: NIH NIGMS R35 DoD CDMRP DMD IDEA Award Arkansas Bioscience Institute University of Arkansas Engineering & Honors Colleges Lab & Team: The Nelson Lab is a dynamic, interdisciplinary team working at the intersection of gene editing, biomaterials, and regenerative medicine. They regularly present at national conferences such as ASGCT and NCUR, and mentor undergraduate researchers through SURF and Honors College grants.

• Gene therapy
• Regenerative medicine
• Genome editing
• +7 more

Dr. Daniel Roxbury is an Associate Professor and Graduate Director at the Department of Chemical, Biomolecular and Materials Engineering within the University of Rhode Island's College of Engineering. With expertise in nanoscience and carbon nanomaterials, his research focuses on nano-bio interactions, developing functionalized nanotubes for biomedical applications and environmental monitoring through his NanoBio Engineering Laboratory. His work spans multiple disciplines including: Biomedical nanosensors Smart wearable biomaterials Targeted drug delivery systems Environmental nanotechnology Single-molecule imaging Nanotoxicology Recent publications emphasize machine learning-enhanced spectral analysis, coral reef conservation nanotechnology, and wearable stress monitoring textiles. His 2024 ACS Nano study introduces AI-driven macrophage phenotyping, while 2023 Nature Nanotechnology work explores coral reef restoration strategies using nanomaterials. Awarded the 2019 NSF CAREER grant for cellular nanometrology, he leads multiple NIH-funded projects including: $820,000 NSF CAREER: Spectral Imaging for Sub-Cellular Nanometrology $140,000 Miriam Hospital COBRE: Cortisol Detection Textiles $700,000 NSF EAGER: Multiplexed Wound Biomarker Detection His laboratory houses state-of-the-art equipment including: Near Infrared Hyperspectral Microscope Custom NIR Fluorescence Spectrometer Jasco UV/VIS/NIR Spectrophotometer Biosafety Cabinet Cell Culture Incubator Cryo-Storage System

• Nanoscience
• Carbon Nanotubes
• Nanomaterials
• +4 more

Zion Zibly, MD, MBA is an Associate Professor in the Department of Neurosurgery at Yale School of Medicine . He holds multiple leadership roles including Director of the Center of Neuromodulation , Director of the Center of Neurosurgical Cancer Pain , and Head of Stereotactic & Functional Neurosurgery and the Focused Ultrasound Institute . Previously served as Chair of Neurosurgery at Sheba Medical Center after graduating from Technion’s Faculty of Medicine (MD) and Coller School of Management (MBA). Research Interests: Specializes in Neuromodulation for movement disorders (Parkinson’s, tremors, dystonia), Deep Brain Stimulation , Gene Therapy for pediatric neurodegenerative conditions, Oncological Neurosurgery , and Neurological Pain Management . Combines Functional Neurosurgery with Focused Ultrasound technology. Scientific Contributions: Participated in pioneering Alzheimer’s brain stimulator procedures and Gene Therapy applications. Active member of the North American Association of Functional Neurosurgery and Israeli Neurosurgical Society . Clinical Expertise: Implantation of electrostimulators for Parkinson’s and essential tremor, treatment of Benign/Malignant CNS Tumors , and management of Neurological Pain Conditions . Affiliated with Yale Cancer Center and Center for Brain & Mind Health .

• Neurosurgery
• Functional Neurosurgery
• Neuromodulation
• +3 more

Jonathan Conway is an Assistant Professor in the Department of Chemical and Biological Engineering at Princeton University and an associated faculty member of the High Meadows Environmental Institute (HMEI). He leads the Conway Lab, which focuses on engineering plant-microbe interactions for applications in bioagriculture, bioenergy, and biochemical industries. Education: B.S. Chemical Engineering, University of Notre Dame (2011) M.S. Chemical Engineering, North Carolina State University (2013) Ph.D. Chemical Engineering, North Carolina State University (2017) Postdoctoral Fellow, University of North Carolina Chapel Hill & Howard Hughes Medical Institute (2017-2021) Research Interests: The Conway Lab develops genetic engineering approaches for non-model bacteria at plant-microbe interfaces. Key research areas include: chemical signaling between plants and microbes, microbiome impacts on plant immunity, environmental stress responses in agricultural systems, and enzymatic degradation of lignocellulosic biomass using thermophilic bacteria. The lab employs bacterial genetics, systems biology, and biomolecular engineering to create technologies for sustainable bioindustries. Publication Trends: Recent work demonstrates strong emphasis on molecular mechanisms of plant-microbe communication (2020-2024), enzyme characterization in biomass degradation (2024-2025), and development of synthetic microbial communities for climate resilience (2024). Earlier research focused on extremophile enzymology and metabolic engineering (2012-2019). Student Advising: Currently mentors 4 graduate students and 8 undergraduates. Alumni include 9 former advisees who graduated between 2022-2024. The lab actively recruits students through Princeton's Chemical Engineering graduate program and undergraduate research initiatives. Laboratory: The Conway Lab develops microfluidic systems for root microbiome studies and genetic tools for engineering plant-associated bacteria. Current projects include designing thermophilic microbial consortia for consolidated bioprocessing and characterizing bacterial immune evasion strategies.

• Plant-microbe interactions
• Biomolecular engineering
• Systems biology
• +4 more

Chao Wang is an Associate Professor at the Department of Chemical and Biomolecular Engineering within the Whiting School of Engineering at Johns Hopkins University. He also serves as the Director of the Nano Energy Laboratory and the department’s Master’s Admissions Director. His research focuses on sustainable energy systems and nanomaterials for CO2 capture and conversion, electrocatalysis, thermocatalysis, and green chemical engineering. Education: Bachelor’s degree, University of Science and Technology of China (2004) Doctorate, Brown University (2009) Wang’s research targets efficient energy conversion and storage via nanomaterials with tailored atomic structures, emphasizing catalytic activity, selectivity, and stability. His group explores electrochemical and thermochemical processes for reduced carbon footprints, including CO2 and methane conversion, ammonia recovery, and phosphorus/nitrogen nutrient recycling using zeolite-based systems. Recent publications (2021–2024) highlight his work in high-entropy alloys, solid-state battery materials, CO2 electroreduction, and biomedical nanotechnologies. Collaborative efforts span catalysis, nanoparticle dynamics, and environmental applications. Grants include a $1M DOE award for multi-university research, a $625K DOE grant for electrified transportation systems, and $3M in startup funding for carbon-removal technology commercialization. Alumni under his mentorship include Ph.D. graduates like Michael J. Manto (2018) and Master’s students like Mitchell Keller (2018), with notable achievements in catalyst development for ammonia/phosphorus recovery and industry placements at Grace & Co. and GEA Engineering.

• CO2 Capture and Conversion
• Electrocatalysis
• Thermocatalysis
• +3 more

Matthew Green is a tenured Professor in the Department of Chemical Engineering at Arizona State University , where he has been since 2014. He serves as Director of the Center for Negative Carbon Emissions and Associate Director of the Biodesign Center for Sustainable Macromolecular Materials and Manufacturing . Director, Center for Negative Carbon Emissions Associate Director, Biodesign Center for Sustainable Macromolecular Materials and Manufacturing Research Focus : Design of ion-containing polymers for water purification , CO2 capture , and nanocomposites , with emphasis on electrostatic interactions, microstructure control, and stimuli-responsive materials. Key thrusts include membrane technology , epoxy thermosets , nanoparticle templating , and electrospun fibers . Publication Trends : Recent work spans zwitterionic polymers for anti-scaling membranes, phosphonium-based DAC systems , silica nanocomposites , and biomaterials for immunotherapy , reflecting interdisciplinary expertise in polymer chemistry , environmental engineering , and materials science . Awards & Grants : 2019 NSF CAREER Award 2018 NASA Early Career Faculty Award 2022 Sloan Foundation Grant DOE DAC Pre-Commercial Technology Prize (2023) Multiple DURIP grants Email : mdgreen8@asu.edu

• Polymer Science
• Sustainable Materials
• Carbon Dioxide Capture
• +5 more

Jennica Zaro, PhD, serves as Associate Professor of Pharmacology and Pharmaceutical Sciences at the University of Southern California (USC) School of Pharmacy and Assistant Dean for Assessment in the Office of Graduate Education and Postdoctoral Studies. Previously, she held academic leadership roles at West Coast University School of Pharmacy and directed the Translational Research and Histology laboratories at USC Mann. Education: PhD in Pharmaceutical Sciences, University of Southern California BS, Stockton University Her pioneering research focuses on engineering recombinant fusion proteins for targeted drug delivery, particularly developing liver-specific insulin therapies for diabetes and pH-sensitive nanoconstructs for tumor targeting. This interdisciplinary work bridges protein engineering, nanomedicine, and translational pharmacology to create site-specific therapeutic systems with enhanced efficacy and reduced side effects. Analysis of her recent publications reveals a cohesive research trajectory centered on protein-drug conjugates, with significant contributions in pH-responsive delivery systems (2017-2018) and liver-targeted insulin analogs (2016-2018). Her work consistently appears in high-impact journals like Journal of Controlled Release and Biomaterials , demonstrating expertise in translating molecular designs into therapeutic applications. Scientific Awards: Most Innovative Award (2017, West Coast University) Advisor of the Year Award (2017, West Coast University, School of Pharmacy) Dr. Zaro has secured substantial research funding as Principal Investigator for NIH National Cancer Institute projects (2013-2016) and USC Ming Hsieh Institute grants (2014-2015), plus consultancy roles with Juvenile Diabetes Research Foundation (2016-2018). She actively shapes national research policy through service on NIH and UK Medical Research Council review panels and the American Foundation for Pharmaceutical Education Board of Grants. Her laboratory expertise includes the Translational Research and Histology core facilities at USC Mann, and she maintains active roles in professional organizations including the Controlled Release Society, American Association of Pharmaceutical Scientists, and American Association of Colleges of Pharmacy.

• Targeted Drug Delivery
• Recombinant Fusion Proteins
• Protein Drugs
• +4 more